Trisenox 12 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
7680651780020
CH-65178
Konzentrat
Associated product:
TRISENOX conc perf 12 mg/6ml 10 flac 6 ml
1 / 2
google
Article details
- Package size
- 10
- Selling units
- 10
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
12.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
4.14 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 3450.75
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2020
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 65178
- Drug name
- Trisenox, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01XX27
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 10/12/2014
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- TRISENOX conc perf 12 mg/6ml 10 flac 6 ml
- Description (DE)
- TRISENOX Inf Konz 12 mg/6ml 10 Durchstf 6 ml
- Market launch
- 27/06/2019
- Narcotic (BTM)
- No
Other package sizes (1)
TRISENOX conc perf 10 mg/10ml 10 amp 10 ml
10 AMP
GTIN: 7680651780013